A drug release-facilitating mechanism for human serum albumin in reverse micelles: requirement of a structural switch.
We measured the binding of a drug oxyphenylbutazone to the N-terminal peptic fragment of human serum albumin in 0.1 M Tris buffer, pH 8.0 (Kass = 2.4 10(5) M-1) and in reverse micelles of sodium bis(2-ethylhexyl) sulfosuccinate and buffer in isooctane (Kass. = 2.7 10(5) M-1). In the absence of any measured change in conformation of the fragment in reverse micelles, the peptide affinity for the drug is not decreased, in contrast to what is observed in intact albumin (HSA) under similar conditions. The interaction and the subsequent unfolding of HSA at the membrane-mimetic interface, constitutes thus a drug release-facilitating mechanism.
Desfosses
B
B
Département de Biochimie, UFR Biomédicale des Saints-Pères, Paris, France.
Nicot
C
C
Waks
M
M
D004337:Drug Carriers / Q000737:chemistry*; D005453:Fluorescence; D006801:Humans; D008823:Micelles; D010113:Oxyphenbutazone / Q000378:metabolism*; D012709:Serum Albumin / Q000737:chemistry*
D004337:Drug Carriers; D008823:Micelles; D012709:Serum Albumin; D010113:Oxyphenbutazone